CN106581468A - Preparation method of traditional Chinese medicine capable of treating gastric ulcer - Google Patents
Preparation method of traditional Chinese medicine capable of treating gastric ulcer Download PDFInfo
- Publication number
- CN106581468A CN106581468A CN201610975012.5A CN201610975012A CN106581468A CN 106581468 A CN106581468 A CN 106581468A CN 201610975012 A CN201610975012 A CN 201610975012A CN 106581468 A CN106581468 A CN 106581468A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- gastric ulcer
- decoction
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 66
- 201000005917 gastric ulcer Diseases 0.000 title claims abstract description 28
- 208000007107 Stomach Ulcer Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 238000009835 boiling Methods 0.000 claims abstract description 4
- 229940079593 drug Drugs 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 11
- 241001057584 Myrrha Species 0.000 claims description 11
- 238000007654 immersion Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 6
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- 210000003298 dental enamel Anatomy 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract 3
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 241001522232 Pinellia ternata Species 0.000 abstract 1
- 240000000513 Santalum album Species 0.000 abstract 1
- 235000008632 Santalum album Nutrition 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000007244 Zea mays Nutrition 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010019375 Helicobacter infections Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 2
- 229960000620 ranitidine Drugs 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017815 Gastric perforation Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(1e)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC OJLOPKGSLYJEMD-URPKTTJQSA-N 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 229960005249 misoprostol Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method of a traditional Chinese medicine capable of treating gastric ulcer. The method comprises the following steps that the traditional Chinese medicine is prepared from, by weight, 12-16 parts of fructus aurantii, 12-20 parts of sandalwood, 15-19 parts of white atractylodes rhizomes, 10-12 parts of asparagus cochinchinensis, 10-15 parts of pinellia ternata, 10-16 parts of rough melic herb, 6-12 parts of elecampane, 6-10 parts of cloves, 12-16 parts of Chinese yams, 10-18 parts of medicinal cyathula roots, 12-16 parts of myrrh and 8-14 parts of rhizoma picrorhizae. All traditional Chinese bulk pharmaceutical chemicals are soaked with clean water or purified water; the soaked traditional Chinese bulk pharmaceutical chemicals and liquid medicine obtained after soaking of the traditional Chinese bulk pharmaceutical chemicals are added into a medicine boiling container, a lid is added for joint decoction; after decoction is completed, liquid medicine is filtered out, and the obtained liquid medicine is used for oral administration. The method has the advantages that on the basis of cognition of the gastric ulcer symptom mechanism and treatment principle, the direct oral administration method is adopted, tonification and purgation in combination are achieved, and the effects of tonifying the spleen and the stomach, promoting blood circulation to remove blood stasis, tonifying qi and nourishing the stomach are achieved, the quality is easy to control, the stability is good, and no adverse reaction exists basically.
Description
Technical field
The present invention relates to the field of Chinese medicines, is a kind of Chinese medicinal preparation method that can treat gastric ulcer specifically.
Background technology
Gastric ulcer is a kind of clinical most commonly seen digestive system disease, and patient is mainly shown as that epigastrium is chronic, rule
Property pain.The generation of gastric ulcer and heredity, life(Long-term alcohol or to take nonsteroidal antiinflammatory drug, diet irregular), spirit
Factor(Psychentonia, anxiety)Relevant, in recent years, research shows, helicobacter pylori infections are that the important of gastric ulcer generation is caused a disease
Reason, therefore, when gastric ulcer is treated, Helicobacter pylori Infection is also key.Gastric ulcer easily recurs, and the course of disease is long, to trouble
The quality of life of person causes serious impact.And easily there are various complication, such as gastric perforation, gastric cancer in gastric ulcer PD
Deng.With the quickening of people's rhythm of life, people's chronic dietary is irregular, psychentonia, overworked, causes gastric ulcer
Sickness rate rises year by year, it has also become one of important diseases of serious harm human health.
According to the pathogenic factor and characteristics of incidence of gastric ulcer, the key agents of the western medical treatment of current gastric ulcer are including antiacid
Agent(Sodium bicarbonate, sodium hydroxide), proton pump inhibitor(Omeprazole, lansoprazole etc.), H2 receptor blocking agent(Sago is replaced
Fourth, ranitidine, Famotidine etc.), gastric mucosa protective agent(Misoprostol etc.), anti-helicobacter pylori class medicine(Metronidazole
Deng), but western medical treatment has therapeutic effect undesirable, large side effects, the shortcoming for easily recurring.The traditional Chinese medical science thinks, Mechanism of Gastric Ulcer
Basic factor is weakness of the spleen and stomach, and the important pathology link of morbidity is stagnant heat, shows as simulataneous insufficiency and excessive, cold and heat patients w ith peptic ulcer disease wrong more
It is miscellaneous.In recent years, for the Chinese traditional treatment of gastric ulcer also gradually causes the concern and attention of people, also occur in that on market more
The Chinese medicine preparation for the treatment of gastric ulcer, the such as Radix Astragali build middle ball, Chaihushugan Pill, WEIDE peace capsule, but these Chinese medicine ingredients are complicated,
Patient can cause untoward reaction after long-term taking, still.
The content of the invention
It is an object of the invention to provide a kind of evident in efficacy, instant effect, can treating in gastric ulcer of having no side effect
Medicament preparation.
The present invention is achieved through the following technical solutions:A kind of Chinese medicinal preparation method that can treat gastric ulcer, including it is following
Several steps:
Step S1:In parts by weight, weigh 12 ~ 16 parts of Fructus Aurantii, 12 ~ 20 parts of Lignum Santali Albi, 15 ~ 19 parts of the Rhizoma Atractylodis Macrocephalae, 10 ~ 12 parts of Radix Asparagi, half
10 ~ 15 parts of summer, 10 ~ 16 parts of Herba Melicae Scabrosae, 6 ~ 12 parts of the Radix Aucklandiae, 6 ~ 10 parts of Flos Caryophylli, 12 ~ 16 parts of Rhizoma Dioscoreae, 10 ~ 18 parts of Radix Cyathulae, Myrrha
12 ~ 16 parts, 8 ~ 14 parts of Rhizoma Acori Calami, 10 ~ 16 parts of Lignum Santali Albi;
Step S2:By above-mentioned whole raw material of Chinese medicine medicines, to be soaked 30 minutes with clear water or pure water in advance, water consumption for immersion is 0.9 ~
1.1L;
Step S3:The liquid medicine of the raw material of Chinese medicine medicine after immersion and its immersion is added in decocting container, is added a cover and is decocted jointly;
Step S4:First make decocting container herb liquid seethe with excitement with high heat, reuse slow fire and boil 15 ~ 20 minutes, 2 need to be stirred when boiling medicine
~ 3 times;
Step S5:After the completion of decoction, medicinal liquid is leached, obtain medicinal liquid and be endo-medicine.
Described step S3 includes following step:
Step S301:First Fructus Aurantii, Lignum Santali Albi, the Rhizoma Atractylodis Macrocephalae, Radix Asparagi are added in decocting container and are decocted 10 minutes with small fire;
Step S302:The Rhizoma Pinelliae, Herba Melicae Scabrosae, the Radix Aucklandiae, Flos Caryophylli are added in decocting container are again decocted 10 minutes with small fire;
Step S303:Rhizoma Dioscoreae, Radix Cyathulae, Myrrha, Rhizoma Acori Calami are added in decocting container again.
Described step S2 ~ S5 is decoction for the first time, also including step S6:
Second decoction is carried out using 0.7 ~ 0.8L clear water or pure water repeat step S3 ~ S5;
Third time decoction is carried out using 0.5 ~ 0.6L clear water or pure water repeat step S3 ~ S5.
Described first time decocts and carries out two hours, and second decoction is carried out one hour, and third time is decocted and carries out one hour.
Described decocting container is marmite, enamel ware or rustless steel, avoids and uses ironware.
A kind of crude drug pharmacology of Chinese medicine formula that can treat gastric ulcer of the present invention:
Fructus Aurantii:It is warm in nature, bitter in the mouth, pungent, acid.Returns spleen Jing, stomach.Regulating the flow of QI to ease the stomach, the stagnant relieving distension of row.Category QI regulating medicine.
Lignum Santali Albi:It is warm in nature, acrid in the mouth.Return lung Jing, stomach, spleen channel, heart channel.Circulation of qi promoting warming middle-JIAO, appetizing pain relieving.Category QI regulating medicine.
The Rhizoma Atractylodis Macrocephalae:It is warm in nature, sweet in the mouth, hardship.Returns spleen Jing, stomach.It is spleen invigorating, QI invigorating, eliminate dampness and have diuretic effect, hidroschesis, antiabortive.Under category qi-restoratives medicine
The Qi-tonifying drug of category classification.
Radix Asparagi:It is cold in nature, sweet in the mouth, hardship.Return lung Jing, kidney channel.Nourishing YIN to relieve dryness, the lung moistening and production of body fluid promoting.The benefit of category qi-restoratives medicine subordinate's classification
Cloudy medicine.
The Rhizoma Pinelliae:Warm in nature, acrid in the mouth is poisonous.Returns spleen Jing, stomach, lung meridian.Drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.Category is clear
The heat clearing and dampness removing medicine of medicine of a warm nature subordinate classification.
Herba Melicae Scabrosae:It is cool in nature, sweet in the mouth.Return through without.Heat clearing away, expelling summer-heat, diuresis.The inducing diuresis to remove edema of category damp-clearing drug subordinate's classification
Medicine.
The Radix Aucklandiae:It is warm in nature, acrid in the mouth, hardship.Returns spleen Jing, stomach, large intestine channel, tri-jiao channel, gallbladder meridian.Promoting the circulation of QI to relieve pain, strengthening the spleen to promote digestion.Category
QI regulating medicine.
Flos Caryophylli:Acrid in the mouth, it is warm in nature.Return stomach, spleen channel, kidney channel.Warming middle-JIAO to send down the adverse QI, reinforcing the kidney and supporting YANG.Category drugs for dispelling internal cold.
Rhizoma Dioscoreae:It is mild-natured, sweet in the mouth.Returns spleen Jing, lung meridian, kidney channel.Spleen reinforcing nourishing the stomach, engender liquid and benefic lung, the kidney invigorating arresting seminal emission.Under category qi-restoratives medicine
The Qi-tonifying drug of category classification.
Radix Cyathulae:It is mild-natured, sweet in the mouth, slight bitter.Return liver warp, kidney channel.Eliminating blood stasis and inducing menstruation, easing joint movement, inducing diuresis for treating stranguria syndrome.Category promoting blood circulationization
The blood-activating and menstruation-regulating medicinal of stasis of blood medicine subordinate classification.
Myrrha:It is mild-natured, acrid in the mouth, hardship.Thoughts of returning home warp, Liver Channel, spleen channel.Scattered stasis pain, detumescence and promoting granulation.Lower point of drug for invigorating blood circulation and eliminating stasis of category
The blood-activating analgesic of class.
Rhizoma Acori Calami:It is warm in nature, it is bitter in the mouth, pungent.Thoughts of returning home warp, Liver Channel, stomach.Stomach warming, anti-inflammatory analgetic.Category digestantss.
The present invention compared with prior art, with advantages below and beneficial effect:
The present invention is to be based on understanding and the Therapeutic Principle to gastric ulcer symptom mechanism, the directly oral method of employing, reinforcement and elimination in combination,
With strong taste, blood circulation promoting and blood stasis dispelling, QI invigorating nourishing the stomach effect, evident in efficacy, quality is easily controlled, good stability, substantially invariably
Good reaction.
Specific embodiment
The present invention is described in further detail with reference to embodiment, but embodiments of the present invention not limited to this.
Embodiment 1:
A kind of Chinese medicine formula that can treat gastric ulcer, including 12 ~ 16 parts of Fructus Aurantii by weight, 12 ~ 20 parts of Lignum Santali Albi, the Rhizoma Atractylodis Macrocephalae 15
~ 19 parts, 10 ~ 12 parts of Radix Asparagi, 10 ~ 15 parts of the Rhizoma Pinelliae, 10 ~ 16 parts of Herba Melicae Scabrosae, 6 ~ 12 parts of the Radix Aucklandiae, 6 ~ 10 parts of Flos Caryophylli, Rhizoma Dioscoreae 12 ~ 16
Part, 10 ~ 18 parts of Radix Cyathulae, 12 ~ 16 parts of Myrrha, 8 ~ 14 parts of Rhizoma Acori Calami.
The method of the present embodiment medicine preparation, including following step:
Step S1:In parts by weight, weigh 12 ~ 16 parts of Fructus Aurantii, 12 ~ 20 parts of Lignum Santali Albi, 15 ~ 19 parts of the Rhizoma Atractylodis Macrocephalae, 10 ~ 12 parts of Radix Asparagi, half
10 ~ 15 parts of summer, 10 ~ 16 parts of Herba Melicae Scabrosae, 6 ~ 12 parts of the Radix Aucklandiae, 6 ~ 10 parts of Flos Caryophylli, 12 ~ 16 parts of Rhizoma Dioscoreae, 10 ~ 18 parts of Radix Cyathulae, Myrrha
12 ~ 16 parts, 8 ~ 14 parts of Rhizoma Acori Calami, 10 ~ 16 parts of Lignum Santali Albi;
Step S2:By above-mentioned whole raw material of Chinese medicine medicines, to be soaked 30 minutes with clear water or pure water in advance, water consumption for immersion is 0.9 ~
1.1L;
Step S3:The liquid medicine of the raw material of Chinese medicine medicine after immersion and its immersion is added in decocting container, is added a cover and is decocted jointly
Two hours, dosing included following step:
Step S301:First Fructus Aurantii, Lignum Santali Albi, the Rhizoma Atractylodis Macrocephalae, Radix Asparagi are added in decocting container and are decocted 10 minutes with small fire;
Step S302:The Rhizoma Pinelliae, Herba Melicae Scabrosae, the Radix Aucklandiae, Flos Caryophylli are added in decocting container are again decocted 10 minutes with small fire;
Step S303:Rhizoma Dioscoreae, Radix Cyathulae, Myrrha, Rhizoma Acori Calami are added in decocting container again;
Step S4:First make decocting container herb liquid seethe with excitement with high heat, reuse slow fire and boil 15 ~ 20 minutes, 2 need to be stirred when boiling medicine
~ 3 times;
Step S5:After the completion of decoction, medicinal liquid is leached, obtain medicinal liquid and be endo-medicine;
Step S6:Second decoction is carried out one hour using 0.7 ~ 0.8L clear water or pure water repeat step S3 ~ S5;
Third time is carried out using 0.5 ~ 0.6L clear water or pure water repeat step S3 ~ S5 to decoct one hour.
Embodiment 2:
Including 12 parts of Fructus Aurantii by weight, 20 parts of Lignum Santali Albi, 15 parts of the Rhizoma Atractylodis Macrocephalae, 10 parts of Radix Asparagi, 15 parts of the Rhizoma Pinelliae, 10 parts of Herba Melicae Scabrosae, wood
Fragrant 6 parts, 6 parts of Flos Caryophylli, 16 parts of Rhizoma Dioscoreae, 18 parts of Radix Cyathulae, 12 parts of Myrrha, 14 parts of Rhizoma Acori Calami.
Embodiment 3:
Including 16 parts of Fructus Aurantii by weight, 20 parts of Lignum Santali Albi, 15 parts of the Rhizoma Atractylodis Macrocephalae, 12 parts of Radix Asparagi, 13 parts of the Rhizoma Pinelliae, 14 parts of Herba Melicae Scabrosae, wood
Fragrant 10 parts, 9 parts of Flos Caryophylli, 16 parts of Rhizoma Dioscoreae, 15 parts of Radix Cyathulae, 16 parts of Myrrha, 10 parts of Rhizoma Acori Calami.
Embodiment 4:
Including 13 parts of Fructus Aurantii by weight, 16 parts of Lignum Santali Albi, 17 parts of the Rhizoma Atractylodis Macrocephalae, 11 parts of Radix Asparagi, 14 parts of the Rhizoma Pinelliae, 12 parts of Herba Melicae Scabrosae, wood
Fragrant 11 parts, 8 parts of Flos Caryophylli, 13 parts of Rhizoma Dioscoreae, 14 parts of Radix Cyathulae, 13 parts of Myrrha, 11 parts of Rhizoma Acori Calami.
Toxicology test:
Acute toxicity test:
Experimental observation, because measuring LD50, therefore has carried out the measure of maximum dosage-feeding.Chinese medicine compound prepared by embodiment 1
Mixture is dissolved in sterile saline, is configured to solution gavage mice, is as a result shown, is given birth to medicine maximum administration concentration 9.65
Medicine/ml, maximum administered volume 50ml/kg was administered twice in 24 hours to mouse stomach, and mice maximum dosage-feeding is 763.25g
There is not untoward reaction and death, each internal organs no abnormality seen of anatomic observation in crude drug/kg, animal.
Long term toxicity test:
This test applies SD rats 80, Chinese medicine compound mixture prepared by embodiment 1 to be dissolved in sterile saline, configures
Into solution gavage, if matched group and 24g, 35g, 49g crude drug/kg dosage groups, continuous gavage is administered 12 weeks, in the observation present invention
Impact of the drug composition to animal indices.Result of the test shows, successive administration 12 weeks, and the Chinese medicine composition of the present invention is to big
Body weight, food ration, peripheral hemogram, clotting time, electrocardiogram, organ index of Mus etc. have no significant effect;Blood biochemical 12
Item index determining result, 12 weeks low dose group BiLi values of administration are higher than matched group(P<0.05);Low dose group, middle dose group TP value
Higher than matched group(P<0.05), but within normal physiologic range, other indexs compare no significant difference with matched group.Recover
Phase, each administration group indices measured value compared equal no significant difference with matched group.The each internal organs gross examination of skeletal muscle no abnormality seen of each group.
The clinical statisticses data of various patients w ith peptic ulcer diseases is directed to using medicine of the present invention:
Through the Clinical practice of 50 patients, wherein male patient 27, female patient 23, medication age object 20 ~ 50 years old.Wherein most
It is little 21 years old, maximum 49 years old, 28 years old mean age.
Zhang, man, people from Jiangsu, 48 years old, gastroscopy the year before be multiple gastric ulcer, clinical symptoms based on having a stomach-ache,
Recently the pain increased, and emits to back, both sides of the chest and chest, and taking the medicines such as ranitidine, Losec can make remission, but be discontinued
Recur immediately afterwards, patient takes the present invention and has a stomach-ache alleviations after ten days, stool is normal, is emotionally stable, spirit is preferable.Continuous medication three
Recheck after the individual course for the treatment of, ulcer healing, it is certainly modern good to continue medication after treatment one month.
The above, is only presently preferred embodiments of the present invention, not does any pro forma restriction to the present invention, it is every according to
According to any simple modification, equivalent variations that the technical spirit of the present invention is made to above example, the protection of the present invention is each fallen within
Within the scope of.
Claims (5)
1. a kind of Chinese medicinal preparation method that can treat gastric ulcer, it is characterised in that:Including following step:
Step S1:In parts by weight, weigh 12 ~ 16 parts of Fructus Aurantii, 12 ~ 20 parts of Lignum Santali Albi, 15 ~ 19 parts of the Rhizoma Atractylodis Macrocephalae, 10 ~ 12 parts of Radix Asparagi, half
10 ~ 15 parts of summer, 10 ~ 16 parts of Herba Melicae Scabrosae, 6 ~ 12 parts of the Radix Aucklandiae, 6 ~ 10 parts of Flos Caryophylli, 12 ~ 16 parts of Rhizoma Dioscoreae, 10 ~ 18 parts of Radix Cyathulae, Myrrha
12 ~ 16 parts, 8 ~ 14 parts of Rhizoma Acori Calami;
Step S2:By above-mentioned whole raw material of Chinese medicine medicines, to be soaked 30 minutes with clear water or pure water in advance, water consumption for immersion is 0.9 ~
1.1L;
Step S3:The liquid medicine of the raw material of Chinese medicine medicine after immersion and its immersion is added in decocting container, is added a cover and is decocted jointly;
Step S4:First make decocting container herb liquid seethe with excitement with high heat, reuse slow fire and boil 15 ~ 20 minutes, 2 need to be stirred when boiling medicine
~ 3 times;
Step S5:After the completion of decoction, medicinal liquid is leached, obtain medicinal liquid and be endo-medicine.
2. a kind of Chinese medicinal preparation method that can treat gastric ulcer according to claim 1, it is characterised in that:Described step
Rapid S3 includes following step:
Step S301:First Fructus Aurantii, Lignum Santali Albi, the Rhizoma Atractylodis Macrocephalae, Radix Asparagi are added in decocting container and are decocted 10 minutes with small fire;
Step S302:The Rhizoma Pinelliae, Herba Melicae Scabrosae, the Radix Aucklandiae, Flos Caryophylli are added in decocting container are again decocted 10 minutes with small fire;
Step S303:Rhizoma Dioscoreae, Radix Cyathulae, Myrrha, Rhizoma Acori Calami are added in decocting container again.
3. a kind of Chinese medicinal preparation method that can treat gastric ulcer according to claim 1, it is characterised in that:Described step
Rapid S2 ~ S5 is decoction for the first time, also including step S6:
Second decoction is carried out using 0.7 ~ 0.8L clear water or pure water repeat step S3 ~ S5;
Third time decoction is carried out using 0.5 ~ 0.6L clear water or pure water repeat step S3 ~ S5.
4. a kind of Chinese medicinal preparation method that can treat gastric ulcer according to claim 3, it is characterised in that:Described
Once decocting is carried out two hours, and second decoction is carried out one hour, and third time is decocted and carries out one hour.
5. a kind of Chinese medicinal preparation method that can treat gastric ulcer according to claim 1, it is characterised in that:Described decocts
Medicine container is marmite, enamel ware or rustless steel, avoids and uses ironware.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610975012.5A CN106581468A (en) | 2016-11-07 | 2016-11-07 | Preparation method of traditional Chinese medicine capable of treating gastric ulcer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610975012.5A CN106581468A (en) | 2016-11-07 | 2016-11-07 | Preparation method of traditional Chinese medicine capable of treating gastric ulcer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106581468A true CN106581468A (en) | 2017-04-26 |
Family
ID=58589724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610975012.5A Withdrawn CN106581468A (en) | 2016-11-07 | 2016-11-07 | Preparation method of traditional Chinese medicine capable of treating gastric ulcer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106581468A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107468857A (en) * | 2017-08-29 | 2017-12-15 | 成都泠汐尚品科技有限公司 | A kind of Chinese medicinal preparation method that can treat gastric ulcer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199809A (en) * | 2007-12-19 | 2008-06-18 | 牟秉芳 | Chinese medicine prescription oral administration for treating gastric ulcer |
CN104225378A (en) * | 2014-09-25 | 2014-12-24 | 刘会焕 | Traditional Chinese medicine composition for treating stomach ulcer and preparation method of traditional Chinese medicine composition |
-
2016
- 2016-11-07 CN CN201610975012.5A patent/CN106581468A/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199809A (en) * | 2007-12-19 | 2008-06-18 | 牟秉芳 | Chinese medicine prescription oral administration for treating gastric ulcer |
CN104225378A (en) * | 2014-09-25 | 2014-12-24 | 刘会焕 | Traditional Chinese medicine composition for treating stomach ulcer and preparation method of traditional Chinese medicine composition |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107468857A (en) * | 2017-08-29 | 2017-12-15 | 成都泠汐尚品科技有限公司 | A kind of Chinese medicinal preparation method that can treat gastric ulcer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN104338062A (en) | Chinese medicinal preparation for treating stomachache and diarrhea | |
CN102319294B (en) | Double-vanilla preparation and preparation method thereof | |
CN105287812A (en) | Medicine composition for treating irritable bowel syndromes and application of medicine composition | |
CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
CN1541676A (en) | Health care medicine for enriching blood in puerperium and its preparation and uses | |
CN105311492A (en) | Medicine for treating coronary atherosclerotic heart disease | |
CN107468857A (en) | A kind of Chinese medicinal preparation method that can treat gastric ulcer | |
CN104491459A (en) | Traditional Chinese medicine composition for treating tumors | |
CN104548029A (en) | Pharmaceutical composition for treating epigastric pain | |
CN106581468A (en) | Preparation method of traditional Chinese medicine capable of treating gastric ulcer | |
CN103585585A (en) | Traditional Chinese medicine composition for treating choledocholithiasis and preparation method thereof | |
CN101327293B (en) | Capsules for treating peptic ulcer and preparation method thereof | |
CN103768408B (en) | A kind of medicine preventing and treating anal and intestinal disease postoperative pain | |
CN102940693A (en) | Medicine composition for treating diabetic foot | |
CN103041233A (en) | Pharmaceutical composition for treating infantile diarrhea and preparation method thereof | |
CN104784650A (en) | Pharmaceutical preparation for clinical nursing of gastric ulcer | |
CN101045116B (en) | Traditional Chinese medicine for treating cholecystitis | |
CN104771734B (en) | A kind of Chinese medicine composition for treating chronic cardiopulmonary disease | |
CN106581469A (en) | Traditional Chinese medicine prescription for treating gastric ulcer | |
CN102631618A (en) | Traditional Chinese medicine for treating diabetes | |
CN105327066A (en) | Method for preparing traditional Chinese medicinal composition for treating postpartum hypogalactia | |
CN105079094A (en) | Traditional Chinese medicine composition for treating hemafecia | |
CN107744555A (en) | A kind of Chinese medicine preparation that can treat gastric ulcer | |
CN103735868B (en) | A kind of preparation method of anal and intestinal disease postoperative bag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170426 |
|
WW01 | Invention patent application withdrawn after publication |